Single-blind, placebo-controlled dose-modification study of vigabatrin in refractory epileptic patients

Journal of Epilepsy - Tập 5 - Trang 248-252 - 1992
Roberto Michelucci1, Paolo Cavaciocchi2, Patrizia Riguzzi1, Daniela Passarelli1, Lucio Parmeggiani1, Mario Santangelo1, Monica Zamagni1, Alfonso Ludice3, Carlo Alberto Tassinari1
1Merrell Dow Research Institute, Winnersh, UK
2Department of Neurology, University of Bologna, Bologna, Italy
3Department of Internal Medicine, Bellaria Hospital, Bologna, Italy

Tài liệu tham khảo

Jung, 1977, Gamma-vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice, J Neurochem, 29, 797, 10.1111/j.1471-4159.1977.tb10721.x Grove, 1981, Increased gammaaminobutyric acid (GABA), homocarnosine and betaalanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA(4-amino-hex-5-enoic acid), Life Sci, 28, 2431, 10.1016/0024-3205(81)90511-7 Ben Menachem, 1988, Effect of single dose of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy, Epilepsy Res, 2, 96, 10.1016/0920-1211(88)90025-3 Rimmer, 1984, Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy, Lancent, 1, 189, 10.1016/S0140-6736(84)92112-3 Gram, 1985, Gamma-vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy, Ann Neurol, 17, 262, 10.1002/ana.410170307 Loiseau, 1986, Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy, Epilepsia, 27, 115, 10.1111/j.1528-1157.1986.tb03512.x Tartara, 1986, Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study, Epilepsia, 27, 717, 10.1111/j.1528-1157.1986.tb03600.x Browne, 1987, Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up, Neurology, 37, 184, 10.1212/WNL.37.2.184 Tassinari, 1987, Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy, Arch Neurol, 44, 907, 10.1001/archneur.1987.00520210009010 Cocito, 1989, Vigabatrin in complex partial seizures: a long-term study, Epilepsy Res, 3, 160, 10.1016/0920-1211(89)90044-2 Michelucci, 1989, Response to vigabatrin in relation to seizure type, Br J Clin Pharmacol, 27, 119, 10.1111/j.1365-2125.1989.tb03472.x Mumford, 1989, Meta-analysis of European placebo-controlled studies of vigabatrin in drug resistant epilepsy, Br J Clin Pharmacol, 27, 102, 10.1111/j.1365-2125.1989.tb03469.x Remy, 1989, Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy, Br J Clin Pharmacol, 27, 125S, 10.1111/j.1365-2125.1989.tb03473.x Luna, 1989, Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study, Epilepsia, 30, 430, 10.1111/j.1528-1157.1989.tb05322.x Reynolds, 1981, Monotherapy or polytherapy for epilepsy?, Epilepsia, 22, 1, 10.1111/j.1528-1157.1981.tb04327.x Matilainen, 1988, Effect of vigabatrin on epilepsy in mentally retarded patients: a 7-month follow-up study, Neurology, 38, 743, 10.1212/WNL.38.5.743 Rimmer, 1989, Interaction between vigabatrin and phenytoin, Br J Clin Pharmacol, 27, 27, 10.1111/j.1365-2125.1989.tb03458.x